Global Cancer Monoclonal Antibodies Market - Growth, Trend & Forecast (2015-2020) - High Cost for Research & Development - Research and Markets

DUBLIN--()--Research and Markets has announced the addition of the "Global Cancer Monoclonal Antibodies Market - Growth, trend, and forecast (2015-2020)" report to their offering.

The Global Cancer Monoclonal Antibodies Market was valued at USD 27 billion for the year 2015, and is expected to grow at a CAGR of around 8-15% from 2015 to 2020. Cancer is a severe disease, which starts from a single cell; cancer genetically transforms a normal cell into a tumor cell. Gradually, it spreads to more cells.

There is no one definite cause for cancer. The interaction between a person's genetic factor and other external agents (physical carcinogens, such as ultraviolet and ionizing radiation, chemical carcinogens, and biological carcinogens) can roughly be cited as the major cause.

Drugs haven't been able to provide complete cure for any cancer. Moreover, all these drugs available for cancer as chemotherapeutic agents have adverse side-effects because the drugs tend to affect the normal, healthy cells along with the cancerous cells. Hence, there is huge amount of research and development going on all over the world to combat this deadly disease.

Drivers:

  • Large global patient pool
  • Severity of the disease
  • Unavailability of completely curing drugs
  • Side effects of the existing drugs
  • More specificity of monoclonal antibodies in targeting cancer cells

Challenges:

  • Stringent regulatory guidelines
  • Long duration of research and development
  • Long duration of clinical trials
  • High cost for research and development

Companies Mentioned:

  • Amgen Inc.
  • Bristol Myer Squibb
  • GlaxoSmithKline
  • Roche Holding
  • Spectrum Pharmaceuticals
  • Merck & Co. Inc.
  • Eli Lilly & Co.
  • ImmunoGen Inc.
  • Seattle Genetics
  • Janssen Biotech Inc.
  • Genmab
  • Novartis AG.

Key Topics Covered:

1. Introduction

2. Research Methodology

3. Executive Summary

4. Key Inferences

5. Market Overview and Industry trends

6. Drivers, Restraints, Opportunities

7. Market Segmentation

8. Market segmentation by Geography - Regional Share and forecast

9. Competitive Landscape

10. Key Vendor Analysis

11. Analyst outlook for Investment opportunities

12. Future Outlook of the market

For more information visit http://www.researchandmarkets.com/research/cvrndr/global_cancer

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Biopharmaceuticals

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Biopharmaceuticals